Recent stressful experiences, such as the loss of a loved one or economic insecurity are strong predictors as to whether a person hospitalized for COVID-19 will experience symptoms of long COVID a year later.
1 in 5 people who receive CPR report lucid experiences of death while they are seemingly unconscious and on the brink of death. The lucid experiences appear to be different from hallucinations, dreams, illusions, and delusions. Researchers found during these experiences the brain has heightened activity and markers for lucidity, suggesting the human sense of self, like other biological functions, may not completely stop around the time of death.
A new study reports two doses of the psychedelic compound psilocybin reduced heavy alcohol consumption by 83% when combined with therapy for those with alcohol use disorder.
Neurons that were "born" at the same time show distinct connectivity and activity throughout the life of an animal.
Study reports a three-fold increased risk of developing dementia in older adults with no genetic risk factors for Alzheimer's disease, who experience social isolation and loneliness.
Researchers have discovered a critical role the dorsal precentral gyrus plays in how people use the sound of their voices to control how they want the words they speak to sound.
Infection with the SARS_CoV-2 virus causes dials down the action of olfactory receptors, resulting in smell loss associated with COVID-19.
Researchers have identified a specific brain network that becomes active as we plan our replies within a conversation.
Increased levels of dopamine release in the basolateral amygdala as a result of stressful situations during infancy could lead to lasting behavioral issues and social difficulties, a new study reports.
Having at least one person you can rely on to listen to your concerns when you need to talk can help improve cognitive resilience and stave off cognitive decline associated with neurodegeneration and aging.
Researchers report on how a cluster of neurons in the hippocampus may directly regulate metabolism.
Lisdexamfetamine, a drug known to stimulate brain activity, reduces symptoms of sluggish cognitive tempo in adults with ADHD.
